Browse Biotechnology news

National Assembly of South Korea Delegation Visits NanoSurface Biomedical
Quidel to Present at William Blair 39th Annual Growth Stock Conference
Mallinckrodt Announces Election of Carlos V. Paya, M.D., Ph.D. to its Board of Directors

Arcus Biosciences to Present at the Jefferies 2019 Global Healthcare Conference

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced that Terry Rosen, Ph.D., Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, 2019 at...

Business Wire via QuoteMedia - 4 hours ago

QIAGEN’s QuantiFERON®-TB Access development program gains recognition from United Nations initiative for health innovation

New breakthrough test for low-resource, high-burden regions to help in global fight against tuberculosis QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QuantiFERON ® -TB Access, a new solution under development for diagnosis of latent tuberculosis (T...

Business Wire via QuoteMedia - 4 hours ago

Medpace Holdings, Inc. to Present at Jefferies 2019 Healthcare Conference

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in June: Jefferies 2019 Healthcare Conference Location: New York, NY Date: Tuesday, June 4, 2019 Presentation: 8:30 a.m. ET Speakers: August Troen...

Business Wire via QuoteMedia - 4 hours ago

OncoSec Medical Incorporated Announces Proposed Public Offering

SAN DIEGO and PENNINGTON, N.J. , May 21, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a late-stage cancer biotechnology company developing intratumoral gene-delivery immunotherapies, today announced that it intends to offer for sale a combination of s...

PR Newswire via QuoteMedia - 4 hours ago

New Study Shows More Than Half of Teens with Peanut Allergy Visited the E.R., More Than One-Third Required Hospitalization Due to Accidental Exposure to Peanut

-- 4 in 10 Teens believe they have a great or very great chance or certainty of dying from accidental exposure -- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced results of a new study...

Business Wire via QuoteMedia - 4 hours ago

Gilead Sciences to Present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5

Webcast Available Through Gilead Corporate Website Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Daniel O’Day, Gilead’s Chairman and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2019 Global Healthcare Conference in New York ...

Business Wire via QuoteMedia - 4 hours ago

Amgen Announces Voting Results Of Annual Meeting Of Stockholders

THOUSAND OAKS, Calif. , May 21, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced voting results from the Company's Annual Meeting of Stockholders, held in Westlake Village , Calif. Approximately 89 percent of outstanding shares were represented at the meeting. T...

PR Newswire via QuoteMedia - 4 hours ago

CHARTING

YOUR ACCOUNT

Sorry, no results

Sorry, no results